Sino Biopharm

News

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A Pharma.

News

LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.

R&D

In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Boyang Wang, the founder of Immortal Dragons.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.